Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
Chinese scientists: H7N9 treatment makes breakthrough
Chinese Scientists Claim That H7N9 Treatment Has Made A Breakthrough. The study showed that blood plasma levels of angiotensin II were higher in H7N9 patients and could be used to predict their physical deterioration, Xinhua reported.
Beijing, May 7: Chinese scientists have claimed to have found a human blood protein associated with the H7N9 fatality rate. The study, published Tuesday in the Nature Communications, showed that blood plasma levels of angiotensin II were higher in H7N9 patients and could be used to predict their physical deterioration, Xinhua reported.
Angiotensin II is a human protein contained in plasma, the vascular wall, heart and kidney to regulate blood pressure. It is closely linked to acute lung injury.
H7N9 patients with higher levels of angiotensin II carry more viral load, said Li Lanjuan, researcher at the Chinese Academy of Engineering and a specialist in H7N9 prevention.
"It is particularly obvious in the second week of human infection. The angiotensin II level of patients in critical condition keeps going up, while that of mild cases tends to drop," Li said. Li added the new finding could help in clinical practice. Medical personnel could adopt more effective and reliable treatment measures for patients suffering different conditions.
"This study will provide a new perspective to H7N9 pathology and potential treatment for future cases," Ed Gerstner, executive editor of Nature Communications, said.
They collected plasma from 47 H7N9 patients in cities of Hangzhou, Shanghai and Nanjing and analyzed the correlation between angiotensin II and viral load.
H7N9 was first reported in China in March 2013. The virus causes severe disease in humans and often lethal respiratory failure.The country has reported more than 200 human H7N9 cases.
